Cognex VP exercises RSUs, withholds shares for tax
Cognex Corp VP and principal accounting officer Laura Ann MacDonald reported routine equity compensation activity.
Rhea-AI Filing Summary
Cognex Corp VP and principal accounting officer Laura Ann MacDonald reported routine equity compensation activity. On March 15, 2026 she exercised 368 restricted stock units, receiving an equal number of common shares. Of these, 109 shares were automatically withheld at a price of $47.98 per share to cover tax obligations, leaving her with 7,470 common shares held directly after the transactions. Each restricted stock unit represents a right to one Cognex common share, and the grant vests approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the March 15, 2024 grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
368 shares exercised/converted
Exercise
17 txns
Insider
MACDONALD LAURA ANN
Role
VP and PAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 368 | $0.00 | $0.00 |
| Exercise | Common Stock | 368 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 109 | $47.98 | $5K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 24,679 contracts for 24,065 underlying shares (Direct);
Common Stock — 7,470 shares (Direct);
Non-Qualified Stock Option (right to buy) — 243,926 contracts (Direct);
Common Stock — 20 shares (Indirect, By Child)
Footnotes (4)
- F1. This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on March 15, 2026 and are reported herein.
- F2. Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- F3. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- F4. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (March 15, 2024), respectively.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cognex (CGNX) report for Laura Ann MacDonald?
Cognex reported that VP and principal accounting officer Laura Ann MacDonald exercised 368 restricted stock units into common stock on March 15, 2026. This was part of her equity compensation and not an open-market purchase or sale.
What are the vesting terms of the Cognex (CGNX) restricted stock units in this filing?
The restricted stock units vest in three installments: approximately 20% on the first anniversary, 30% on the second, and 50% on the third anniversary of the March 15, 2024 grant. Each vested unit delivers one Cognex common share.
Does the Cognex (CGNX) Form 4 include any indirect holdings for Laura Ann MacDonald?
Yes. The report notes 20 Cognex common shares held by the reporting person’s child as an indirect holding. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, according to the filing’s footnote.
What ongoing equity incentives for Cognex (CGNX) does the Form 4 highlight?
The filing lists multiple non-qualified stock options and restricted stock units covering various amounts of Cognex common stock, with exercise prices from $33.04 to $90.50 and expirations between 2028 and 2036. These represent potential future share acquisitions if conditions are met.
AI-generated analysis. How Rhea-AI works. Not financial advice.
